Filing Signals

Source: SEC EDGAR Compiled 2026-08-23 04:41 UTC Unattended

← All events

NUTRA PHARMA CORP

CIK 1119643 NPHC·Manufacturing · All EDGAR filings ↗

Late filing Filing comparison

NUTRA PHARMA CORP told the SEC it could not file its quarterly report on time

Does not expect a significant change in results.

The Form 10-Q could not be filed within the prescribed time because additional time is required by Registrant’s management and auditors to prepare certain financial information to be included in such report.
Evidence
Anticipates significant change
False
Other periodic reports filed
True
Severity
normal
Source
Form 12b-25 (notification of late filing)
Stated reason
The Form 10-Q could not be filed within the prescribed time because additional time is required by Registrant’s management and auditors to prepare certain financial information to be included in such report.
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.